Early, routine testing for HIV is key to curbing the disease among teens

This study, which will be published in the December issue of the Journal of Adolescent Health and is currently available online, is the first to take a prospective look at the factors associated with HIV testing among adolescents.

“Our goal was to determine why some high-risk teens would get tested for HIV, and others would not,” explained lead author Marina Tolou-Shams, Ph.D., of the Bradley Hasbro Children's Research Center and an assistant research professor of psychiatry with The Warren Alpert Medical School of Brown University.

Researchers assessed the sexual behavior, substance use and HIV testing behaviors of 1,222 sexually active adolescents, ages 15 to 21, from Providence, Miami, and Atlanta over three months. They found that teens were more likely to get tested for HIV if they’ve already been tested before. In fact, approximately half of all study subjects had a history of HIV testing, and of those, one-third got tested within three months – even without having gone through a specific HIV testing intervention.

“These findings were a bit surprising, since we thought teens would be more likely to get an HIV test if they engaged in risky behaviors, such as substance use during sex, or attended an HIV prevention workshop,” said senior author Larry K. Brown, M.D., of the Bradley Hasbro Children’s Research Center and a professor of psychiatry and human behavior at Alpert Medical School. “Given that a history of HIV testing appears to be a major motivator for adolescents to get tested in the future, a widespread HIV testing approach could help control the spread of this disease among our nation’s at-risk youth.”

Adolescents who received HIV testing during the three-month study were also more likely to have a sexually transmitted disease, to be assertive about condom use with their partner, and to not use drugs or alcohol during sex. However, researchers saw no association between having sex with high-risk partners or one's own perceived susceptibility to HIV and getting tested for the disease – although these are some of the reasons that often motivate adults to get tested.

In the study, teens were randomly assigned to either a wait-list control group or a brief, three-hour skills-based group HIV prevention intervention based on Project LIGHT – a National Institute of Mental Health/National Institute of Health-funded multi-site trial for young adults at high risk for HIV. Baseline and three-month follow-up interviews were administered.

Based on these results, the authors conclude that it is critical for HIV testing to be made more readily available to adolescents in order to increase the chances that they will seek future HIV testing as they engage in more HIV high-risk behaviors. They also advocate for public health campaigns that focus on incorporating HIV testing as part of the general practice of being proactive about one's own health to also help increase rates of adolescent HIV testing.

“Implementing testing throughout various nontraditional adolescent venues, such as schools and community settings (e.g., boys and girls clubs, YMCA) could increase future testing thereby making more adolescents aware of their positive HIV status and reducing future HIV transmission among youth,” the authors said.

Source: Lifespan

Study reveals gap in HIV testing knowledge among college students
Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
How 'hidden mutations' contribute to HIV drug resistance
One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.
Simian foamy virus found in several people living and working with monkeys in Asia
A research team led by University of Washington scientists has found that several people in South and Southeast Asian countries working and living around monkeys have been infected with simian foamy virus (SFV), a primate virus that, to date, has not been shown to cause human disease. The findings provide more evidence that Asia, where interaction between people and monkeys is common and widespread, could be an important setting for future primate-to-human viral transmission. The study appears in the August issue of the journal Emerging Infectious Disease.
NIAID will not move forward with the PAVE 100 HIV Vaccine Trial
After soliciting and considering broad input from the scientific and HIV advocacy communities, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has determined that it will not conduct the HIV vaccine study known as PAVE 100.
Researchers: Program discourages HIV transmission in Russia
(Boston)-Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found that sexual behavior counseling during drug addiction treatment should be considered an important component among Russian substance-dependent individuals, in order to decrease risky sexual behavior in the HIV at-risk population. This study appears in the journal Addiction.
Vaginal microbicides may prevent more infections in men than women
Vaginal microbicides currently in clinical trials may be the only weapon that will protect women against infection from HIV. Yet, under likely circumstances, these microbicides may be of more benefit to men than women, according to a new UCLA AIDS Institute study.
Researchers demonstrate safety of gene therapy using adult stem cells
A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy to cure diseases of the blood, bone marrow and certain types of cancer do not cause the development of tumors or leukemia. The study was published online in the May 6, 2008 issue of Molecular Therapy.

Early, routine testing for HIV is key to curbing the disease among teens

Related stories:

News discussion: